Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma.
Bioorg Med Chem Lett
; 28(17): 2985-2992, 2018 09 15.
Article
en En
| MEDLINE
| ID: mdl-30122227
A series of squaramide-based hydroxamic acids were designed, synthesized and evaluated against human HDAC enzyme. Squaramides were found to be potent in the Hut78 cell line, but initially suffered from low solubility. Leads with improved solubility and metabolic profiles were shown to be class I, IIB and IV selective.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Quinina
/
Neoplasias Cutáneas
/
Linfoma Cutáneo de Células T
/
Histona Desacetilasa 1
/
Histona Desacetilasa 2
/
Inhibidores de Histona Desacetilasas
/
Antineoplásicos
Límite:
Humans
Idioma:
En
Revista:
Bioorg Med Chem Lett
Asunto de la revista:
BIOQUIMICA
/
QUIMICA
Año:
2018
Tipo del documento:
Article
Pais de publicación:
Reino Unido